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     Adenosine Deaminase is an aminohydrolase (EC 3.5.4.4) which participates in the purine 
metabolism where it degrades either adenosine or 2'-deoxyadenosine producing inosine or 2'-
deoxyinosine, respectively. The enzyme contains a parallel alpha/beta -barrel motif with eight central 
beta strands and eight peripheral alpha helices. ADA is located both in the cytosol and on the cell 
membrane. Since spermine, a natural metabolite, exists in all cells and tissues and its effect on the cell 
proliferation and enzyme regulation have been reported,  thermal inactivation of the ADA and spermine 
regulatory effect on the ADA activity have been investigated in this study. Percentage of ADA activity 
in the presence and absence of spermine (1000 µM) in Tris buffer 50 mM, pH 7.5 at physiologic and 
pathologic temperatures have been reported in the present study. Thermal inactivation curves for ADA 
in the absence and presence of spermine (1000 µM) in different temperatures ranging from 55 oC to 70 
oC have been drawn. Our data showed that spermine activates the enzyme in the low concentrations of 
adenosine at 37 oC. However, it inhibits ADA activity at 42 oC in the same concentrations of substrate. 
It is concluded that spermine regulatory effect depends on combined influence of temperature and 
adenosine concentration. Furthermore, thermal stability of the enzyme also depends on temperature in 
presence of spermine. Binding site of spermine on the enzyme has been identified by docking analysis. 
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INTRODUCTION 
     Adenosine Deaminase (ADA) is a cytosolic 
enzyme, which has been the object of 
considerable interest, mainly because in human 
a congenital defect in the enzyme causes severe 
combined immunodeficiency disease (SCID). 
ADA is an aminohydrolase (EC 3.5.4.4) which 
participates in the purine metabolism where it 
degrades either adenosine or 2’-deoxyadenosine 
producing inosine or 2’- deoxyinosine, 
respectively. The enzyme is widely distributed 
and many of its biochemical properties have 
been studied in different species [1]. The 
product of human ADA gene consists of 363 
amino acids (41 kDa) and there is a high degree 
of amino acids sequence conservation amongst 
species. The enzyme contains a parallel α/ß-
barrel motif with eight central β strands and 
eight peripheral α helices, which is a common 
structure found in 1/10 of known enzymes [2]; it 
also contains five additional helices.  
Chang et al. (1991) proposed that catalytic 
functions are carried out by Cys 262, Asp 295, 
Asp 296, and His 214 of the mammalian 
adenosine deaminases. The zinc ion is 
coordinated by His 15, His 17, His 214 and Asp 
295. In humans, the highest ADA activity is 
found in thymus and other lymphoid tissues 
(~800 IU/mg), the lowest in erythrocytes (~1 
IU/mg) [3]. ADA is located both in the cytosol 
and on the cell membrane. Recent evidence 
suggests that ecto-ADA had extra-enzymatic 
and co-stimulatory functional roles. ADA 
modulates ligand binding and signaling through 
A1R on DDT1MF-2 cells, a smooth muscle cell 
line [4-5]. ADA seems to be necessary for the 
high affinity binding of agonists to A1R [6-7].  
The human enzyme is genetically polymorphic 
and is found in 2 electrophoretically distinct 
forms termed ADA-1 and ADA-2 [8]. In 
addition three variants that exhibit apparent 
molecular weight values in different ranges have 
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been described among vertebrates [9-10]. These 
forms have been designated A (M.W. > 
200,000), B (M.W. ~ 100,000), and C (M.W ~ 
35,000). Tissues of higher mammals generally 
lack the B form and are characterized by 
varying ratios of A and C. Human erythrocytes 
[8] contain almost exclusively the type C form, 
whereas other tissues contain varying amounts 
of the high-molecular-weight species [11]. 
 Serum ADA levels increase in pancreatic 
disorders, especially in pancreatic cancer. It may 
be a serum marker for the diagnosis of 
pancreatic cancer [12]. ADA is involved in 
some diseases such as: Behçet s disease (BD) 
[13], tuberclosis [14], brain tumor [15], lung 
cancer and mesothelioma [16]. 
Spermine is one of the natural metabolites of the 
human body. It was introduced for the first time 
as one of the compounds in the sperm and soon 
after scientists realized that spermine exists in 
all cell types as a member of polyamins family 
[17]. The role of polyamines in the cell 
proliferation has been determined as well as 
their role in other cell processes [18, 19].These 
kinds of components have positive charge, 
therefore, their interaction with negative charge 
of the macromolecules such as DNA [20, 21], 
proteins [22] and enzymes [23] for regulating 
the function and stabilizing the structure have 
been reported. These findings and also this fact 
that polyamines functions are firmly controlled 
by several regulating mechanisms represent 
their important role in the cell function [24, 25]. 
Polyamines also play an important role in stress 
conditions especially in thermal stress [26-27]. 
Therefore, their role as a natural metabolites 
could be important in physiologic response to 
environmental stresses. 
Previous findings indicate that concentration of 
polyamines increases in colon cancer, lung, 
prostate and breast cancer [28-33]. Furthermore, 
the relation between adenosine deaminase, (the 
enzyme that exists in all cell types) and different 
type of cancers [34-36] suggests that there 
might be a relation between ADA and poly 
amine functions. These molecules participate in 
the regulation of glutamate receptor function 
and also some of the ion channels, especially 
calcium channel [37-41]. According to these 
statements and the fact that polyamines are able 
to regulate the protein and enzyme functions 
[23, 42], in the present study the regulatory 
effect of spermine (as a final product of poly 
amine biosynthesis pathway and as the most 
important poly amine in the body) on the ADA 
activity has been investigated in vitro. 
Moreover, based on polyamine roles in thermal 
stability of enzymes [43], and also the 
importance of thermal stability changes of 
adenosine deaminase by biologic ligands [44-
45], in the present study, the authors have 
investigated the effect of spermine on thermal 
stability of adenosine deaminase.  
 
MATERIALS AND METHODS 
     Calf intestine adenosine deaminase was 
purchased from Roche. Adenosine (as 
substrate), spermine and Tris base were 
purchased from Sigma.  
 
Enzyme assay 
Adenosine deaminase was assayed after an 
overnight dialysis against 50 mM, pH 7.5 Tris 
buffer to removed excess glycerol molecules as 
preservative in commercial product. The 
enzyme assays were done by measuring the 
decreased absorption of substrate in 265 nm and 
using Spectronic 601 UV-Vis 
spectrophotometer instrument. The enzyme 
solution (94 Unit/ml) was prepared in 1 ml final 
volume of standard mixture. Enzyme activity 
was measured in 12 different concentrations of 
adenosine from 2 ×10-2 µM to 38 ×10-2  µM in 
50 mM pH 7.5 Tris buffer and every point was 
repeated three times. The averages were 
illustrated as the relation of enzyme activity in 
the presence of spermine 1000 µM  to enzyme 
activity in the absence of spermine in term of 
percentage at 37 oC and 42 oC. Polyamines have 
a wide concentration range in body tissues (17-
18) therefore here the best responding 
concentration of spermine for this enzyme (1000 
µM) is selected by some simple experiments. 
The enzyme activity in the absence of 
spermine (a0) was assayed as a function of 
substrate concentrations. This experiment 
was carried out for the enzyme in the 
presence of spermine 1000 µM (a1). The 
percentage of activity changes (∆Act % ) in 
the presence of spermine was calculated by 
equation 1: 
∆Act % =100(a1-a0)/a0                      (1) 
Thermal inactivation of ADA: 
Thermal inactivation of Adenosine deaminase 
was studied in the range of 55 oC to 70 oC 
(minimum and maximum temperatures of 
irreversible inactivation for ADA during 40 
minutes) in the absence and presence of 
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spermine. The final mixture of sample was 
composed of 94 Unit/ml enzyme, spermine 
1000 µM and Tris buffer 50 mM, pH 7.5. The 
sample mixture was incubated about 40 minutes 
in different temperatures from 55 to 70 oC and 
enzyme activity was assayed every 5 minutes in 
one fixed concentration of adenosine which 
corresponded to Vmax. Thermal inactivation 
constant (ki) was calculated from slope of the 
linear part of the absolute logarithm of residual 
activity against incubation time. 
 
Docking analysis 
Hex is interactive graphics for calculating and 
displaying feasible docking modes or pairs of 
protein and DNA molecules. Hex reads protein 
and DNA molecular structures from PDB-
format files. Up to three PDB files can be 
loaded into hex at any one time. These are 
treated as a receptor, a ligand and a reference 
complex. Using this graphic program (Hex), 
force energy (the binding energy of ligand) and 
shape energy were calculated and the spermine 
binding site on the enzyme and the involved 
amino acid residues was predicted. 
 
RESULTS   
     Adenosine deaminase, an enzyme distributed 
in the human tissues [11], was considered as 
good marker of cell mediated immunity [46]. It 
plays a crucial role in lymphocyte proliferation 
and differentiation [47], and shows its highest 
activity in T- lymphocytes [48], therefore, study 
of ADA activity in physiological and 
pathological temperatures (infectious 
conditions) would be helpful for understanding 
the mechanism of immune system indirectly in 
such conditions and in the presence of spermine 
as an important metabolite which is involved in 
some cell processes.  
Figure 1 shows the percentage of changes in 
enzyme activity induced by of 1000 µM 
spermine at 37 oC as well as 42 oC. 
The docking analysis by HEX software revealed 
that spermine has a binding site on the enzyme 
molecule which is composed of α-helices and 
coils related to amino acids 105-107, 214 and 
265-287, in addition the binding parameters of 
Eforce (binding energy of ligand), Eshape (energy 
content of the protein) and E total (E force+Eshape) 
are -31.5, -120.6 and -152.1 J, respectively 
(Figure 2).  
Because of polyamines role in thermal stability 
of enzymes [43] and the importance of 
adenosine deaminase stability as an important 
enzyme in immune processes and critical 
enzyme in purine catabolism, the effect of 
spermine on the thermal stability of ADA has 



































Figure 1. The relation of ADA activity in the presence of 
spermine (1000 µM) to the enzyme activity in the absence 
of spermine in term of percentage of activity changes at 37 
oC and 42 oC 
 
 
         
 
     
 
Figure 2. The docking analysis for binding site of a 
spermine molecule on adenosine deaminase molecule 
 
 
Natural logarithm of residual activity against 
incubation time in different temperatures in the 
absence of spermine and presence of 1000 µM 
spermine is represented in the figures 3 and 4 
respectively. 
spermin
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Figure 3. Natural logarithm of residual activity against 


























Figure 4. Natural logarithm of residual activity against 
incubation time for different temperatures in the presence 
of 1000 µM spermine 
 
 The thermal inactivation of the enzyme was 
studied in different temperatures from 55 oC to 
70 oC in the absence and presence of 1000 µM 
spermine. The temperatures below 55 oC were 
overlooked, because the slopes of the curves 
were zero or near zero. The slope of ADA 
inactivation curves is considered as thermal 
inactivation constant (ki). Figure 5 shows 
changes of ki against temperature in the 



















Figure 5. The changes of thermal inactivation constant 




     As it is depicted in the figure 1, spermine 
induces 63% activation and 30% inhibition in 
the ADA activity at 37 oC. At 42 oC, the values 
are 8% and 25%, respectively. The standard 
deviation of each point was not more than 10% 
of related average. 
At 37 oC, spermine can induced ADA activity 
(up to 60 percent of the activity in the absence 
of spermine) in the substrate concentrations 
below 0.25 µM. But in higher concentrations of 
substrate, spermine decreases ADA activity 
(maximum inhibition is about 30 percent). It can 
be deduced that spermine effect on ADA 
activity is depend on substrate concentration at 
this temperature. The observation may be 
related to probable conformational changes in 
the enzyme molecules due to substrate binding 
to the binding site(s) other than active site [49].  
Despite of 37 oC, spermine mostly inhibits ADA 
activity (maximum 25% inhibition) in almost all 
substrate concentrations (except of some 
substrate concentrations that ADA has been 
activated less than 8%). It seems that, at 42 oC, 
changes in ADA activity by spermine are less 
dependent to substrate concentration than 37 oC.  
Moreover, spermine effect at physiologic 
temperature is reversed in comparison with 
pathologic temperature in the most applied 
concentrations of adenosine. The maximum 
difference between two temperatures is 
observed in concentrations bellow 0.1 µM 
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adenosine which corresponds with adenosine 
concentration in plasma and adipose tissue. 
Interestingly, the maximum activation effect of 
spermin (63%) at physiological temperature is 
belonging to mentioned concentration ranges of 
substrate. On the other hand, spermine inhibits 
the enzyme activity about 20% at pathologic 
temperature in the same range of substrate. This 
may have a physiological or pathological 
importance. These interpretations are true apart 
from the fact that the activity changes are 
reversible or irreversible.  
The results show that spermine can activate or 
inhibit ADA activity depend on two factors: 
temperature and substrate concentration. We 
have already showed that temperature changes 
can induce conformational changes in ADA 
molecules [50]. On the other hand, a mentioned 
before, substrate molecules can bind to the 
binding site(s) other than active site and change 
its function probably due to inducing a 
conformational change in the enzyme molecule. 
The enzyme conformational change, in turn, 
may affect on the binding of spermine on its 
binding site and/or its effectiveness on ADA 
enzymatic activity change. 
Thermal inactivation curve is usually a 
logarithmic curve in most of the enzymes and ki 
raises in logarithmic manner with temperature 
increase [51]. Therefore, thermal inactivation 
curve of ADA deviates from normal manner. ki 
of ADA increases at 65 oC in the absence of 
spermine, It means that ADA is stabilized 
abruptly at low and high temperatures of 65 oC. 
The presence of 1000 µM  spermine does not 
eliminate this abrupt increment, but moderates 
its intensity and shifts it to low temperatures 
(this kind of behavior has not be reported for 
other protein). Spermine destabilizes ADA by 
increasing ki at high temperatures as well as at 
60 oC but stabilizes the enzyme at 65 oC. 
Spermin has not any obvious effect on ADA 
stability at 55 and 63 oC. It seems that spermine 
affects on ADA stability by a temperature 
dependent manner. This observation is 
compatible with its effect on ADA activity 
(Figure 1). Therefore, it is concluded that the 
quality of spermine effect on thermal 
inactivation depends on temperature. The results 
of the study on the spermine effect on the ADA 
activity and thermal inactivation propose that 
ADA may have a flexible structure and its 
conformation is sensitive to environment which 
caused various activity and stability under the 
physical  (e.g. temperature) and chemical (e.g. 
binding of some ligands and substrate) 
conditions. Since temperature, substrate and 
spermine concentrations are changed under 
several stresses and diseases [26-32], alteration 
in activity and stability of ADA [12-16] (as a 
key enzyme in purine metabolism especially in 
immune system) may have important roles in 
clinical issues.  
According to docking analysis, it is concluded 
that spermine as a natural metabolite could bind 
to ADA and spermine binding might affect the 
ADA activity and ADA stability as well.   
     Spermine as a natural ligand activates 
ADA enzyme at physiological temperature 
in the certain concentrations of subestrate. 
The regulatory effect of spermine on ADA 
activity diminishes at pathological 
temperatures. Spermin also effects on ADA 
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